Fibrin monomer and fibrinopeptide B act additively to increase DNA synthesis in smooth muscle cells cultured from human saphenous vein

Journal of Vascular Surgery

Volumn 33, Issue 4, 2001, Pages 847-853

  Sturge, Justin ^b   Carey, Nessa ^b   Davies, Alun H ^b   Powell, Janet T ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; BROXURIDINE; COLLAGEN; CYCLIC AMP; DNA; FIBRIN DEGRADATION PRODUCT; FIBRINMONOMER; FIBRINOGEN; FIBRINOPEPTIDE B;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

BROMODEOXYURIDINE; CELL DIVISION; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA; CYCLIC AMP; DNA; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOPEPTIDE B; HUMANS; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN; SERUM ALBUMIN, BOVINE;

EID: 0035321606     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.111984     Document Type: Article

References (28)

1. Resch KL, Ernst E. Fibrinogen and viscosity: risk factors for cardiovascular events. Compr Ther 1994;20:170-3.
2. Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 1995;92:31-8.
3. Tschopl M, Tsakiris DA, Marbet GA, Labs KH, Jager K. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Thromb Vasc Biol 1997;17:3208-14.
4. Bosmans JM, Kockx MM, Vrints CJ, Bult H, DeMeyer GRY, Herman AG. Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. Arterioscler Thromb Vasc Biol 1997;17:634-45.
5. Wiseman S, Kenchington G, Dain R, Marshall CE, McCollum CN, Greenhalgh RM, et al. Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ 1989;299:643-6.
6. Hicks RC, Ellis M, Mir H, Higman DJ, Nott D, Greenhalgh RM, et al. The influence of fibrinogen concentration on the development of vein graft stenoses. Eur J Vasc Endovasc Surg 1995;9:415-20.
7. Weiss HJ, Turitto VT, Baumgartner HR. Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium: studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest 1986;78:1072-82.
8. Tijburg PN, Ijsseldijk MJ, Sixma JJ, De Groot PG. Quantification of fibrin deposition in flowing blood with peroxidase-labeled fibrinogen: high shear rates induce decreased fibrin deposition and appearance of fibrin monomers. Arterioscler Thromb 1991;11:211-20.
9. Mailhac A, Badimon JJ, Fallon JT, Fernandez O, Meyer B, Chesebro JH, et al. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis: relative contribution of fibrin(ogen) and platelets. Circulation 1994;90:988-96.
10. Gray AJ, Bishop JE, Reeves JT, Laurent GJ. A-alpha and B-beta chains of fibrinogen stimulate proliferation of human fibroblasts. J Cell Sci 1993;104:409-13.
11. Gray AJ, Pyong WP, Broekelmann TJ, Laurent GJ, Reeves JT, Stenmark KR, et al. The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin. J Biol Chem 1995;270:26602-6.
12. Sporn LA, Bunce LA, Francis CW. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood 1995;86:1802-10.
13. Levesque J, Hatzfeld A, Hudry C, Wilner GD, Hatzfeld J. Evidence for two functionally different fibrinogen receptors on hemopoietic cells. J Cell Physiol 1987;132:303-10.
14. Robson SC, Saunders R, Purves LR, De Jager C, Corrigall A, Kirsch RE. Fibrin and fibrino-gen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis. Blood 1993;81:3006-14.
15. Gardiner EE, D'Souza, SE. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem 1997;272:15474-80.
16. Gardiner EE, D'Souza SE. Sequences within fribronogen and intercellular adhesion molecule-1 (ICAM-1) modulate signals required for mitogenesis. J Biol Chem 1999;274:11930-6.
17. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-8.
18. Dubey RK, Jackson EK, Rupprecht HD, Sterzel RB. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens 1997;6:88-105.
19. Schor SL. Cell proliferation and migration on collagen substrata in vitro. J Cell Sci 1980;41:159-75.
20. Martin GR, Sank AC. Extracellular matrices, cells, and growth factors. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors II. Berlin: Springer-Verlag; 1990. p, 463-77.
21. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R, Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 1996;87:1069-78.
22. Indolfi C, Avvedimento EV, Di LE, Esposito G, Rapacciuolo A, Giuliano P, et al. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle proliferation induced by vascular injury. Nat Med 1997;3:775-9.
23. Campbell GR, Campbell JH. Phenotypic modulation of smooth muscle cells in primary culture. In: Campbell GR, Campbell JH, editors. Vascular smooth muscle in culture. 1st ed. Boca Raton: CRC; 1987. p. 39-55.
24. Weitz JI, Leslie B. Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin. J Clin Invest 1990;86:203-12.
25. Ishida T, Tanaka K. Effects of fibrinogen and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis 1982;44:161-74.
26. Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998;273:7554-9.
27. Singh TM, Kadowaki MH, Glagov S, Zarins CK. Role of fibrinopeptide-B in early atherosclerotic lesion formation. Am J Surg 1990;160:156-9.
28. Kadowaki MH, Singh TM, Zarins CK, Glagov S, Meredith SC. The effect of hypercholesterolemia on early atherosclerotic lesions initiated by fibrinopeptide B. J Surg Res 1991;51:524-8.